Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer

Human Pathology

Volumn 41, Issue 12, 2010, Pages 1758-1769

  Kasajima, Atsuko ^a,b   Sers, Christine ^a   Sasano, Hironobu ^b   Jöhrens, Korinna ^a   Stenzinger, Albrecht ^a,c   Noske, Aurelia ^a   Buckendahl, Ann Christin ^a   Darb Esfahani, Silvia ^a   Müller, Berit Maria ^a   Budczies, Jan ^a   Lehman, Annika ^a   Dietel, Manfred ^a   Denkert, Carsten ^a   Weichert, Wilko ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; Inflammation; Major histocompatibility complex; Prognosis; Transporters associated with antigen processing

Indexed keywords

CARRIER PROTEIN; CD20 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLORECTAL CARCINOMA; DOWN REGULATION; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PROGNOSIS; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; AGED; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CD8-POSITIVE T-LYMPHOCYTES; COLON; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM STAGING; PROGNOSIS; RECTUM;

EID: 78449285664     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.014     Document Type: Article

References (54)

1. Jass J.R. Lymphocytic infiltration and survival in rectal cancer J Clin Pathol 39 1986 585 589
2. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 1998 3491 3494
3. + tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability Hum Pathol 35 2004 808 816
4. Menon A.G., Janssen-van Rhijn C.M., and Morreau H. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis Lab Invest 84 2004 493 501
5. Galon J., Costes A., and Sanchez-Cabo F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964
6. Sharma P., Shen Y., and Wen S. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma Proc Natl Acad Sci U S A 104 2007 3967 3972
7. Schumacher K., Haensch W., Röefzaad C., and Schlag P.M. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas Cancer Res 61 2001 3932 3936
8. Kawai O., Ishii G., and Kubota K. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV non small cell lung cancer Cancer 113 2008 1387 1395
9. Lee H.E., Chae S.W., and Lee Y.J. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer Br J Cancer 99 2008 1704 1711
10. Clarke B., Tinker A.V., and Lee C.H. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss Mod Pathol 22 2009 393 402
11. Seliger B. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors Cancer Immunol Immunother 57 2008 1719 1726
12. van den Ingh H.F., Ruiter D.J., Griffioen G., van Muijen G.N., and Ferrone S. HLA antigens in colorectal tumours-low expression of HLA class I antigens in mucinous colorectal carcinomas Br J Cancer 55 1987 125 130
13. Möller P., Momburg F., and Koretz K. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma Cancer Res 51 1991 729 736
14. Menon A.G., Morreau H., and Tollenaar R.A. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients Lab Invest 82 2002 1725 1733
15. Watson N.F., Ramage J.M., and Madjd Z. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis Int J Cancer 118 2006 6 10
16. Ogino T., Shigyo H., and Ishii H. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker Cancer Res 66 2006 9281 9289
17. Han L.Y., Fletcher M.S., and Urbauer D.L. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma Clin Cancer Res 14 2008 3372 3379
18. Natali P.G., Nicotra M.R., and Bigotti A. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors Proc Natl Acad Sci U S A 86 1989 6719 6723
19. Meissner M., Reichert T.E., and Kunkel M. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome Clin Cancer Res 11 2005 2552 2560
20. Kageshita T., Hirai S., Ono T., Hicklin D.J., and Ferrone S. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression Am J Pathol 154 1999 745 754
21. Facoetti A., Nano R., and Zelini P. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors Clin Cancer Res 11 2005 8304 8311
22. Mehta A.M., Jordanova E.S., Kenter G.G., Ferrone S., and Fleuren G.J. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma Cancer Immunol Immunother 57 2008 197 206
23. Seliger B., Ritz U., and Ferrone S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation Int J Cancer 118 2006 129 138
24. Spies T., Cerundolo V., Colonna M., Cresswell P., Townsend A., and DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer Nature 355 1992 644 646
25. + T cells Cell 71 1992 1205 1214
26. Vermeulen C.F., Jordanova E.S., and ter Haar N.T. Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma Gynecol Oncol 105 2007 593 599
27. Vitale M., Rezzani R., and Rodella L. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions Cancer Res 58 1998 737 742
28. Kamarashev J., Ferrone S., and Seifert B. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis Int J Cancer 95 2001 23 28
29. Atkins D., Breuckmann A., and Schmahl G.E. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma Int J Cancer 109 2004 265 273
30. Lou Y., Vitalis T.Z., and Basha G. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival Cancer Res 65 2005 7926 7933
31. Lou Y., Basha G., and Seipp R.P. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival Clin Cancer Res 14 2008 1494 1501
32. Fenoglio-Preiser C., Carneiro F., and Correa P. Gastric carcinoma S.R. Hamilton, A. Aaltonen, Tumours of the digestive system 2000 IARC Press Lyon, France 37 51
33. Weichert W., Röske A., and Niesporek S. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo Clin Cancer Res 14 2008 1669 1677
34. Andersen M.H., Schrama D., Thor Straten P., and Becker J.C. Cytotoxic T cells J Invest Dermatol 126 2006 32 41
35. Waldner M., Schimanski C.C., and Neurath M.F. Colon cancer and the immune system: The role of tumor invading T cells World J Gastroenterol 12 2006 7233 7238
36. + ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells Cancer Immunol Immunother 52 2003 423 428
37. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A 102 2005 18538 18543
38. Liyanage U.K., Moore T.T., and Joo H.G. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761
39. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 2003 1089 1099
40. Curiel T.J., Coukos G., and Zou L. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949
41. Michael-Robinson J.M., Biemer-Hüttmann A., and Purdie D.M. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status Gut 48 2001 360 366
42. Seliger B., Höhne A., and Knuth A. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression Clin Cancer Res 2 1996 1427 1433
43. Henderson R.A., Michel H., and Sakaguchi K. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation Science 255 1992 1264 1266
44. Lautscham G., Rickinson A., and Blake N. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus Microbes Infect 5 2003 291 299
45. Min W., Pober J.S., and Johnson D.R. Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha J Immunol 156 1996 3174 3183
46. Epperson D.E., Arnold D., Spies T., Cresswell P., Pober J.S., and Johnson D.R. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells J Immunol 149 1992 3297 3301
47. Cramer L.A., Nelson S.L., and Klemsz M.J. Synergistic induction of the Tap-1 gene by IFN-gamma and lipopolysaccharide in macrophages is regulated by STAT1 J Immunol 165 2000 3190 3197
48. Brucet M., Marqués L., Sebastián C., Lloberas J., and Celada A. Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1 Genes Immun 5 2004 26 35
49. Sandel M.H., Speetjens F.M., and Menon A.G. Natural killer cells infiltrating colorectal cancer and MHC class I expression Mol Immunol 42 2005 541 546
50. Seliger H.F., Ruiter D.J., Griffioen G., van Muijen G.N., and Ferrone S. HLA antigens in colorectal tumours-low expression of HLA class I antigens in mucinous colorectal carcinomas Br J Cancer 55 1987 125 130
51. Liao N.S., Bix M., Zijlstra M., Jaenisch R., and Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity Science 253 1991 199 202
52. Phillips S.M., Banerjea A., Feakins R., Li S.R., Bustin S.A., and Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic Br J Surg 91 2004 469 475
53. Løvig T., Andersen S.N., and Thorstensen L. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis Br J Cancer 87 2002 756 762
54. Walsh M.D., Dent O.F., and Young J.P. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers Int J Cancer 125 2009 1231 1237